Therefore, the proportion of immune cells including CD4+, CD8+ T cells, and NK cells, the major IFNγ producers, were analyzed in the B16F10 tumor model at the early stage (1, 3, 5, 7d) post ablation (Figure 1A). This evidence concerns the gene CD8A and neoplasm.